Similar articles

• [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression].

  Krel' AA, Kanevskaia MZ, Rashchupkina ZP, Bolotin EV, Chichasova NV. Krel' AA, et al. Ter Arkh. 1982;54(6):82-92. Ter Arkh. 1982. PMID: 7112429 Russian. No abstract available.
• [Chlorbutin, azathioprine, d-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis patients. III. A comparative analysis of their effect on the morphological manifestations of synovitis based on puncture biopsy data].

  Shekhter AB, Krel' AA, Chichasova NV, Rashchupkina ZP. Shekhter AB, et al. Ter Arkh. 1984;56(2):121-31. Ter Arkh. 1984. PMID: 6710393 Russian. No abstract available.
• Rheumatoid arthritis.

  Emery P, Suarez-Almazor M. Emery P, et al. Clin Evid. 2003 Jun;(9):1349-71. Clin Evid. 2003. PMID: 15366179 Review. No abstract available.
• [Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents].

  Faust-Tinnefeldt G, Geissler HE, Mutschler E. Faust-Tinnefeldt G, et al. Arzneimittelforschung. 1977;27(11):2153-7. Arzneimittelforschung. 1977. PMID: 580020 German. No abstract available.
• Immunosuppressive therapy in severe rheumatoid arthritis.

  Dodson WH. Dodson WH. Mod Treat. 1971 Nov;8(4):778-86. Mod Treat. 1971. PMID: 4946106 Review. No abstract available.